Research and clinical trials
Go to Cancer Research UK's clinical trials database if you are looking for a trial for gallbladder cancer in the UK.
Talk to your specialist if there are any trials that you think you might be able to take part in.
Some of the trials on this page have now stopped recruiting people. It takes time before the results are available. This is because the trial team follow the patients for a period of time and collect and analyse the results. We include this ongoing research to give examples of gallbladder cancer research.
Clinical trials are medical research studies involving people. All cancer treatments must be fully researched before they can be used for everyone. This is so we can be sure that:
they work
they are safe
they work better than the treatments already available
The short video below explains what it is like to take part in a trial.
Gallbladder cancer is often diagnosed at an advanced stage. Researchers want to find better ways of diagnosing this type of cancer, and at an earlier stage. They are looking at:
new tests that look for proteins that may act as cancer markers ()
a different type of scan to see whether it can pick up tumours in the liver more clearly
a blood test that can pick up small amounts of cancer . This is the SYMPLIFY study
Find out more about the SYMPLIFY study
Researchers are always looking into ways to improve treatment, reduce side effects, and control symptoms.
Research is continuing into chemotherapy drugs and combinations of chemotherapy drugs to treat gallbladder cancer. Researchers are looking into:
using chemotherapy to stop, or slow down the cancer coming back after surgery
controlling the symptoms of advanced gallbladder cancer
comparing chemotherapy drugs
Targeted cancer drugs are newer drugs and work in a different way to chemotherapy.
Targeted cancer drugs change the way that cells work. They can boost the body’s immune system to fight off or kill cancer cells. Or they can block signals that tell cells to grow.
Researchers are looking into different types of targeted drugs for gallbladder cancer. Targeted cancer drugs that they are looking at include:
pembrolizumab
lenvatinib
durvalumab
entrectinib
selumetinib
zanidatamab
futibatinib
nivolumab
bevacizumab
Researchers are looking at the role of the gut in cancer treatment for people with advanced gallbladder cancer.
A study called ABC-12 is using the immunotherapy drug durvalumab in combination with chemotherapy drugs cisplatin and gemcitabine. The researchers will analyse the bacteria that live in our bowel and mouth to find out if they affect how well treatment works.
Read general information about targeted drugs
A small trial looked at whether acupuncture can reduce nerve damage (peripheral neuropathy) caused by chemotherapy. The trial team found that adding acupuncture to usual treatment helped. It improved the symptoms of nerve damage caused by chemotherapy.
Last reviewed: 07 Nov 2023
Next review due: 07 Nov 2026
If you see a trial on our database that you are interested in, you will usually need to discuss it with your own doctor or cancer specialist.
Advanced gallbladder cancer is cancer that has spread outside the gallbladder into lymph nodes or nearby organs. Or that has spread to another part of the body such as the lungs (secondary or metastatic gallbladder cancer).
Find out about the help and support available if you have advanced gallbladder cancer.
Our clinical trials aim to find out if a new treatment or procedure is safe, is better than the current treatment or helps you feel better.
Gallbladder cancer is when abnormal cells in the gallbladder start to divide and grow in an uncontrolled way.
There are many cancer drugs, cancer drug combinations and they have individual side effects.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.